Henry Schein, Inc. HSIC recently completed the acquisition of substantially all of the assets of Acentus, a national medical supplier specializing in the delivery of continuous glucose monitors (CGMs) ...

Henry Schein announced the agreement to acquire Acentus on November 20, 2024. Headquartered in Tampa, Florida, Acentus reports annual revenue of approximately $35 million. Henry Schein expects the ...

Henry Schein has received a strategic investment of $250 million from KRR, giving the global investment firm a 12% stake in the company, with the option to purchase additional shares ...

Acentus Founders Brett Carroll, Todd Cianfrocca, Greg Duvall, and Julio Valdivia will join Henry Schein, bringing their expertise and experience in the product category and the healthcare industry.

In a report released on January 29, Michael Cherny from Leerink Partners reiterated a Hold rating on Henry Schein (HSIC – Research Report), ...

Henry Schein announced today that private equity firm KKR is investing $250 million in the medical products manufacturer and ...

Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the ...